Welcome address of Vladislav Shestakov for the attendees and guests at the 10^th Anniversary Pan-Russian GMP Conference with international engagement

By Vladislav Shestakov, Deputy Head of the Pharmaceutical Inspectorate of the Russian Federation, Director of the Federal State Budgetary Institution “State Institute of Drugs and Good Practices”, Ministry of Industry and Trade of Russia

Dear colleagues, partners, attendees and guests of the 10^th Pan-Russian GMP Conference with International Engagement,

On behalf of the Federal Budgetary Institution “State Institute of Drugs and Good Practices” of the Ministry of Industry and Trade of Russia, it is my pleasure to welcome you all to the leading event of the year in the field of good practices — the 10^th Anniversary Pan-Russian GMP Conference!

For ten years, the Conference has not only become a prestigious platform for professional collaboration, but a space for sustainable dialogue between regulators, manufacturers, industry experts and scientific communities. This platform provides solutions that contribute to the development of good pharmaceutical practices and strengthening reliance to the local pharmaceutical system, including promotion of quality standards both in Russia and other countries.

This year, we get together in Moscow — a hub for industry, science and education in Russia. Anniversary conference, symbolically takes place in Moscow, highlighting the importance of a systemic approach to industry regulation and each participant’s contribution to the common goal — ensuring patient access to effective, safe and quality medicines.

The Conference program focuses on the entire landscape of current challenges and prospects the pharmaceutical industry is facing. We will discuss the strategic role of good practices in medicines marketing, topical GMP inspection and manufacturing authorization issues, and collaboration within the Eurasian Economic Union (EAEU), focusing on digital transformation and introduction of new technological solutions.

A special focus of the Conference will be set on the development of professional competencies within the pharmaceutical community and harmonization of international standards.

I am confident that the GMP Conference will once again stand as a valuable platform for the exchange of knowledge, experience and best practices, a powerful tool to start new partnerships, joint initiatives, encourage contribution from the industry expert community in shaping and continuous improvement of medicines regulation in response to challenges of modern medical science and technology, and will expand professional horizons.

I would like to thank all participants for their attention to the good practices and contribution to the development of local and global pharmaceutical industry. I wish you all fruitful work, constructive discussions and inspiring meetings!

Sincerely,

Vladislav Shestakov
Deputy Head of the Pharmaceutical Inspectorate of the Russian Federation
Director of the State Institute of Drugs and Good Practices
Ministry of Industry and Trade of Russia

Dear colleagues, partners and participants of the IX All-Russian GMP Conference!

For almost 10 years an event of such scale has been bringing together many pharmaceutical industry professionals. Those who are eager to share their expertise while searching for the best solutions to improve regulatory practices.

Throughout this time Gedeon Richter company has been a regular participant and partner of this important event in the industry. Today good manufacturing practice is not just a set of rules and instructions but a complex puzzle involving many elements: from the quality of substances to the employees’ qualification at the production site. However, such a GMP puzzle is not static. It is constantly changing, being supplemented with new details and improvements. Which, undoubtedly, makes the regulatory process even more complex but at the same time – interesting! Each standard, each procedure is a unique component that, along with others, create a holistic picture of the safety and quality of manufactured drugs.

Throughout the conference we will be solving important problems, looking for new solutions, sharing experience so that every step in the production process is verified, letting the final product meets the highest standards.

I am pleased to welcome all colleagues – the conference participants who strive to make their professional contribution to improving the health and well-being of patients. I wish all of us productive meetings, inspiring ideas and effective solutions!

Good afternoon, esteemed organizers and guests of the IX Pan-Russian GMP Conference!

On behalf of Pharmstandard, I am pleased to welcome all participants of today’s landmark event for the industry. This year, the conference is titled «GMP — Continuous Development», clearly reflecting the ongoing processes.

It would not be an exaggeration to say that the pharmaceutical industry is one of the drivers of the Russian economy, which is currently on the path of dynamic changes. Continuous development of the institute of good practices and constructive dialogue between all participants in the pharmaceutical manufacturing are crucial to achieving success.

I would like to note the significance of the event taking place these days. The Pan-Russian GMP Conference, as already proven by many years of experience in holding it, is a working platform for interaction between all industry participants. Representatives of state regulatory authorities, experts in good practices, members of pharmaceutical manufacturing, industrial unions — all of us at this platform are looking for ways to harmonize and improve key processes for our industry. This includes evaluation of regulatory practices, discussion of issues related to licensing, auditing, development of quality management system, medicinal product manufacturing, activities of industrial unions, and features of entering the markets of other countries.

On the sidelines of the 9th Pan-Russian GMP Conference, I am sure that we will be able to discuss highly topical issues that pharmaceutical market participants face today, find common approaches to law enforcement practices and, in the format of an open discussion, come to mutual understanding and develop constructive solutions. I wish each of us to find seeds for addressing real challenges in the diversity of our colleagues’ experience.

Fruitful work to all conference participants!